DERMATOLOGY NP & PA COMMUNITY
 
Ixekizumab approved for pediatric plaque psoriasis
Eli Lilly announces the U.S. Food and Drug Administration approval of ixekizumab (Taltz) for treatment of moderate-to-severe plaque psoriasis in pediatric patients 6 and under 18 who are also eligible for phototherapy and systemic therapy.
 
HEINE introduces two new dermatoscopes
HEINE, a global primary diagnostic instrument manufacturer, announces two new dermatoscopes available for purchase in the U.S.